Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

Overview of attention for article published in The Journal of Headache and Pain, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 2 news outlets
policy: 1 policy source

twitter: 1 X user

Readers on

mendeley: 59 Mendeley

Summary News Policy documents X

So far, Altmetric has seen 3 news stories from 2 outlets.

Novel Treatments Are Reshaping Migraine Treatment, Prevention

Medscape, 14 Jan 2020

This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener, a neurologist from the University of…

Novel Treatments Are Reshaping Migraine Treatment, Prevention

Medscape, 24 Dec 2019

This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener, a neurologist from the University of…

Study Examines Lasmiditan Used With, Without Migraine Preventives

AJMC, 02 Aug 2019

A new study aimed to examine the effectiveness of lasmiditan when used with migraine preventives compared to those who do not…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.